There is provided 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide for various uses, as well as pharmaceutical compositions and devices comprising 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide. There is also provided a method for reducing reducible compounds (such as reduction-activated prodrugs, e.g. tretazicar) by contacting those compounds with α-hydroxycarbonyl compounds capable of forming cyclic dimers.
提供了用于各种用途的 5-(
氮丙啶-1-基)-
4-羟基
氨基-2-
硝基苯甲酰胺,以及包含 5-(
氮丙啶-1-基)-
4-羟基
氨基-2-
硝基苯甲酰胺的药物组合物和装置。本发明还提供了一种还原可还原化合物(如还原活化原药,如曲他西卡)的方法,该方法是将这些化合物与能够形成环状二聚体的α-羟基羰基化合物接触。